Combination With Gemcitabine in Advanced Pancreatic Cancer
NCT01251640
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Neoplasms
Interventions
DRUG:
BAY86-9766+Gemcitabine
Sponsor
Bayer